In addition, apart from the regulation of FXR, TUDCA administration attenuates HFD-induced hepatic steatosis, inflammatory responses, obesity, and IR in mice by promoting the reconstitution of the intestinal microbiota and improving the intestinal barrier [206]. This evidence concerns the gene NR1H4 and fatty liver disease.